Search Within

Biostatistics Service

Formats
  1. Journal Article (4057)
  2. Meeting Abstract (2453)
  3. Research Letter (55)
  4. Conference Paper (37)
  5. Correspondence (28)
  6. Editorial (26)
  7. Review (23)
  8. Miscellaneous (16)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Epidemiology and Biostatistics (6713)
  2. Department of Medicine (3955)
  3. Solid Tumor Oncology Division (2629)
  4. Survivorship Research (2555)
  5. Surgery (2427)
  6. Population Sciences Research Program (2413)

More Groups

People
  1. Mithat Gonen (1041)
  2. Sean Devlin (618)
  3. Katherine Panageas (525)
  4. Sujata Patil (511)
  5. Sergio Giralt (480)
  6. Zhigang Zhang (434)

More People

Years
  1. 2025 (227)
  2. 2024 (402)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1078)
  2. Blood (468)
  3. Annals of Surgical Oncology (312)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (198)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1148)
  2. Elsevier Inc. (780)
  3. Springer (635)
  4. American Society of Hematology (527)
  5. American Association for Cancer Research (434)
  6. Nature Publishing Group (317)

More Publishers

Results (6713)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Melanoma brain metastasis: Presentation, treatment and outcomes in the age of targeted- and immuno-therapies
    Meeting Abstract

    Bander, E. D.; Yuan, M.; Carnevale, J. A.; Reiner, A. S.; Panageas, K. S.; Postow, M. A.; Tabar, V.; Moss, N. S.
    Neuro-Oncology Advances (2020)

    Fulltext@MSK | Save
  • VRd versus KRd safety profiles in newly diagnosed multiple myeloma patients using real-world evidence data from a single institution: VRd has high rates of chronic neuropathy, and KRd has low rates of cardiopulmonary or renal toxicities when using optimized IV fluid management coupled with baseline cardiac workup
    Meeting Abstract

    Tan, C.; Diamond, B.; Hultcrantz, M.; Korde, N.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Patel, D.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders: A population based study including 94,579 cases and 368,348 matched controls
    Meeting Abstract

    Shah, U. A.; Rögnvaldsson, S.; Derkach, A.; Björkholm, M.; Turesson, I.; David, Y.; Hultcrantz, M.; Tan, C.; Hassoun, H.; Korde, N.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
    Meeting Abstract

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • R-CHOP versus R-Bendamustine with or without rituximab maintenance in newly diagnosed follicular lymphoma patients with high SUV at baseline PET
    Meeting Abstract

    Mondello, P.; Strati, P.; Merryman, R. W.; Joffe, E.; Ruella, M.; Seshan, V.; St Pierre, F.; Major, A.; Pophali, P.; Fiasconaro, M.; more...
    Blood (2020)

    Fulltext@MSK | Save